News Quantified

AMED – amedisys inc (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Amedisys, Inc. (NASDAQ: AMED) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $101.00 price target on the stock.

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises [Yahoo! Finance]

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results [Yahoo! Finance]

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results

UnitedHealth Shares Drop as DOJ Opens Civil Fraud Probe [Yahoo! Finance]

0.1%

MISS

0.1%

MISS

0.1%

MISS

0.1%

MISS

Form 4 AMEDISYS INC For: Mar 04 Filed by: Guidroz Allyson

Form 144 AMEDISYS INC Filed by: Guidroz Allyson

Form 10-K/A AMEDISYS INC For: Dec 31

Form 10-K AMEDISYS INC For: Dec 31

Form 8-K AMEDISYS INC For: Feb 26

Top News Gainers

3/18 Form 4 AMEDISYS INC For: Mar 16 Filed by: Kline Teresa L. 13.3%

3/16 Form 4 AMEDISYS INC For: Mar 12 Filed by: PERKINS BRUCE D 10.6%

11/1 Amedisys Inc (NASDAQ: AMED) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. 10.2%

2/19 Why Amedisys' Q4 Results Could Be a Speed Bump for the High-Flying Stock [The Motley Fool] 4.8%

3/4 Amedisys Inc (NASDAQ: AMED) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 4.5%

4/3 Form 4 AMEDISYS INC For: Apr 01 Filed by: Gerard Christopher 4.3%

4/27 Amedisys Signs Definitive Agreement to Acquire AseraCare Hospice 4.1%

1/7 Amedisys to Present at the J.P. Morgan 38th Annual Healthcare Conference 3.1%

6/3 Form 4 AMEDISYS INC For: May 30 Filed by: Kemmerly David L 2.6%

7/26 Amedisys Inc (NASDAQ: AMED) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 2.6%

Top News Decliners

3/14 Amedisys Inc (NASDAQ: AMED) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -17.3%

3/11 Form 4 AMEDISYS INC For: Mar 09 Filed by: Gerard Christopher -9.5%

4/16 Form 8-K AMEDISYS INC For: Apr 10 -7.1%

10/29 Amedisys Reports Third Quarter 2019 Financial Results and Updates 2019 Guidance -5.6%

3/4 Amedisys to Present at the Oppenheimer 30th Annual Healthcare Conference -4.4%

3/9 Amedisys Inc (NASDAQ: AMED) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $205.00 price target on the stock. -4.4%

4/29 Amedisys to Present at the BofA Securities 2020 Virtual Health Care Conference -3.8%

2/18 Q4/2019 12/31/2019 EPS 0.940 ZacksConsensus 0.930 ActVsEst 0.010 - Beat -3.5%

5/17 Amedisys Inc (NASDAQ: AMED) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -3.5%

2/24 Form 4 AMEDISYS INC For: Feb 20 Filed by: Gerard Christopher -3.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day